Funding {4}
MAY, SCHULTZ
Funding is provided by a Medical Research Future Fund (MRFF) Lifting Clinical Trials and Registries Capacity Grant (GNT1152376). The current funding period ends in May 2024. The funding body will have no role in the design of the study or the collection, analysis, or interpretation or reporting or data. Funding allocation to parties contributing to the study will be administered by the University of Sydney and will be in accordance with a research collaboration agreement. Fellowship support was provided to Schultz by the NHMRC (GNT1168022) and MRFF grants (MRF1193796). Fellowship funding was provided to Snelling by an MRFF Investigator Award (MRF1195153).